Ablation of exterior of stomach to treat obesity

• US 7,282,050 B2
• Filed: 10/31/2003
• Issued: 10/16/2007
• Est. Priority Date: 10/31/2003
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Starkebaum, Warren L., Christopherson, Mark A., Prentice, Thomas R.
• Primary Examiner(s): PEFFLEY, MICHAEL F
• Application Number:
  US10/699,207
• Publication Number:
  US 20050096638A1
• Time in Patent Office: 1,446 Days
• Field of Search: 606/41, 606/49, 606/50, 606/32, 606/40, 607/96, 607/98, 607/100, 607/101, 607/104, 607/105, 128/898
• US Class Current: 606/41
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 18/1492 having a flexible, catheter-like structure, e.g. for heart ablation A61B18/1477 takes precedence
• CPC Class Codes: A61B 18/22 the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
• CPC Class Codes: A61B 2018/00238 porous
• CPC Class Codes: A61B 2018/00494 Stomach, intestines or bowel
• CPC Class Codes: A61B 2018/1425 Needle
• CPC Class Codes: A61B 2018/143 multiple needles
• CPC Class Codes: A61B 2018/1432 curved
• CPC Class Codes: A61B 5/392 Detecting gastrointestinal contractions
• CPC Class Codes: A61B 5/42 Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems A61B1/00, A61B5/4857, A61B5/486, A61B5/4866, A61B5/4869 take precedence

Abstract

The invention provides methods and devices to treat obesity by ablating tissue from an exterior surface of a stomach of a patient. For example, the invention may involve ablation of exterior stomach tissue to alter gastric myoelectric activity or muscle function from the exterior surface of the stomach to produce abnormal gastric peristalsis without damaging the mucosal lining of the stomach. The invention may further provide methods and devices to monitor the gastric myoelectric activity before and after the ablation procedure.

Claims

1. A method for treating obesity comprising ablating tissue on an exterior surface of a stomach of a patient with an ablation probe sized to fit the stomach and further comprising:

monitoring gastric myoelectric activity of the stomach prior to the ablation to determine a baseline digestion rate;

monitoring the gastric myoelectric activity of the stomach after the ablation to determine a post-ablation digestion rate; and

ablating additional stomach tissue based on a comparison of the post-ablation digestion rate to the baseline digestion rate.

2. The method for treating obesity of claim 1, wherein monitoring gastric myoelectric activity comprises recording an electrogastrogram (EGG) of the patient.

3. The method for treating obesity of claim 1, wherein monitoring the gastric myoelectric activity of the stomach after the ablation comprises monitoring the gastric myoelectric activity of the stomach one week after the ablation.

4. The method for treating obesity of claim 1, wherein the baseline digestion rate comprises a baseline rate of gastric emptying and the post-ablation digestion rate comprises a post-ablation rate of gastric emptying.

5. The method for treating obesity of claim 1, wherein the comparison determines whether the ablation has slowed a peristaltic wave.

6. The method for treating obesity of claim 1, wherein ablating tissue comprises ablating at least a portion of at least one of a pacemaker region, interstitial cells of Cajal, smooth muscle cells, a splanchnic nerve, and a vagus nerve.

7. A method comprising:

ablating tissue on an exterior surface of a stomach of a patient with an ablation probe sized to fit the stomach; and

monitoring gastric activity of the stomach after the ablation, wherein monitoring gastric activity comprises assessing the impact of the ablation upon one of gastroparesis, nausea, and gastroesophageal reflax disease.